Therapy News and Research

RSS

Psychologic treatment has long-term benefits for bipolar patients

Psychoeducation and cognitive behavioral therapy combined with pharmacologic treatment provides significant long-term benefits for patients with refractory bipolar disorder, researchers report.

8 Jan 2013

Arterial elasticity link to lung function

People with reduced arterial elasticity may have impaired lung function, and vice versa, say US researchers.

8 Jan 2013

Chronic neck pain patients show respiratory weakness

Chronic neck pain appears to be associated with impaired respiratory function due to weakness of the respiratory muscles, study findings indicate.

8 Jan 2013

Adolescents may lose hepatitis B virus protection despite vaccination as infants

New research reveals that a significant number of adolescents lose their protection from hepatitis B virus (HBV) infection, despite having received a complete vaccination series as infants. Results in the January 2013 issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases, suggest teens with high-risk mothers (those positive for HBeAg) and teens whose immune system fails to remember a previous viral exposure (immunological memory) are behind HBV reinfection.

8 Jan 2013

Esperion reports positive results from ETC-1002 Phase 2 clinical trial on type 2 diabetes

Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo.

8 Jan 2013

Thoratec to start REVIVE-IT study using HeartMate II Left Ventricular Assist System

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that the U.S. Food and Drug Administration has granted an Investigational Device Exemption to commence the REVIVE-IT study utilizing the HeartMate II Left Ventricular Assist System.

8 Jan 2013

FDA approves use of iCAD's PowerLook AMP with Philips MicroDose Digital Mammography System

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced approval by the U.S. Food and Drug Administration for use of the company's next generation mammography computer-aided detection platform, PowerLook Advanced Mammography Platform, with Digital CAD for Philips' MicroDose Full-Field Digital Mammography System.

8 Jan 2013

State roundup: Mo. lawmakers look to cap malpractice awards

A selection of health policy stories from California, Minnesota, Missouri, New York, Texas, Illinois and North Carolina.

8 Jan 2013

Spectrum Pharmaceuticals reveals positive RenaZorb Phase 1 clinical trial results

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced positive, statistically significant data from the Company's Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb (also referred to as SPI-014) in healthy volunteers.

8 Jan 2013

Seven scientists named 2013 recipients of Damon Runyon-Rachleff Innovation Award

The Damon Runyon Cancer Research Foundation announced that seven scientists with novel approaches to fighting cancer have been named 2013 recipients of the Damon Runyon-Rachleff Innovation Award.

8 Jan 2013

Penis shrinkage caution for prostate cancer patients

Men choosing prostate cancer treatment should be informed about the small risk for penis shrinkage, say US researchers who believe discussing the rare side effect could reduce the chance for patient regret.

7 Jan 2013

Benefits of respiratory treatment for extremely premature infants persist

There are no significant differences in death or neurodevelopmental impairment between toddlers who underwent early continuous positive airway pressure or early surfactant administration as extremely premature infants, research shows.

7 Jan 2013

Vaccine gives HIV patients a long-term boost

A functional cure for HIV-1 seems feasible after research shows that an immunotherapeutic vaccine demonstrated long-term efficacy at reducing viral load when administered to patients in the early stages of disease.

7 Jan 2013

Real life experience of defibrillators lives up to clinical trial expectations

There is no significant difference in survival between clinical trial patients who receive an implantable cardioverter and clinical registry patients who receive a primary prevention ICD, researchers suggest.

7 Jan 2013

Complications of suppurative otitis media characterized

Researchers emphasize the importance of an early and accurate diagnosis of chronic suppurative otitis media followed by surgical therapy to prevent complications.

7 Jan 2013

Merck’s resubmission of the NDA for suggammadex sodium injection accepted for review by the FDA

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the resubmission of the New Drug Application (NDA) for sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration (FDA). Merck expects the FDA’s review to be completed in the first half of 2013.

7 Jan 2013

New study compares costs and outcomes associated with prostate cancer treatments

The most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness is reported this week by a team of researchers at the University of California, San Francisco.

7 Jan 2013

Biogen Idec files rFIXFc BLA with FDA for treatment of hemophilia B

Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.

7 Jan 2013

PharmaIN receives FDA orphan-drug designation for terlipressin to treat ascites

PharmaIN Corporation and LAT Pharma LLC today announced that the US Food and Drug Administration (FDA) has granted their request for orphan-drug designation for terlipressin for the treatment of ascites due to all etiologies except for cancer.

7 Jan 2013

Raising transfusion threshold improves acute upper GI bleeding outcomes

Outcomes among patients with acute upper gastrointestinal bleeding can be improved by employing a restrictive transfusion strategy that raises the threshold for the transfusion of red cells, the results of a Spanish study indicate.

4 Jan 2013

Therapy News and Research

Psychologic treatment has long-term benefits for bipolar patients

Arterial elasticity link to lung function

Chronic neck pain patients show respiratory weakness

Adolescents may lose hepatitis B virus protection despite vaccination as infants

Esperion reports positive results from ETC-1002 Phase 2 clinical trial on type 2 diabetes

Thoratec to start REVIVE-IT study using HeartMate II Left Ventricular Assist System

FDA approves use of iCAD's PowerLook AMP with Philips MicroDose Digital Mammography System

State roundup: Mo. lawmakers look to cap malpractice awards

Spectrum Pharmaceuticals reveals positive RenaZorb Phase 1 clinical trial results

Seven scientists named 2013 recipients of Damon Runyon-Rachleff Innovation Award

Penis shrinkage caution for prostate cancer patients

Benefits of respiratory treatment for extremely premature infants persist

Vaccine gives HIV patients a long-term boost

Real life experience of defibrillators lives up to clinical trial expectations

Complications of suppurative otitis media characterized

Merck’s resubmission of the NDA for suggammadex sodium injection accepted for review by the FDA

New study compares costs and outcomes associated with prostate cancer treatments

Biogen Idec files rFIXFc BLA with FDA for treatment of hemophilia B

PharmaIN receives FDA orphan-drug designation for terlipressin to treat ascites

Raising transfusion threshold improves acute upper GI bleeding outcomes

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News